Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 3
2008 3
2009 1
2014 1
2015 2
2016 2
2017 2
2018 2
2019 3
2020 3
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Metallothioneins in Prion- and Amyloid-Related Diseases.
Adam P, Křížková S, Heger Z, Babula P, Pekařík V, Vaculovičoá M, Gomes CM, Kizek R, Adam V. Adam P, et al. Among authors: pekarik v. J Alzheimers Dis. 2016;51(3):637-56. doi: 10.3233/JAD-150984. J Alzheimers Dis. 2016. PMID: 26923022 Review.
Perspective of Use of Antiviral Peptides against Influenza Virus.
Skalickova S, Heger Z, Krejcova L, Pekarik V, Bastl K, Janda J, Kostolansky F, Vareckova E, Zitka O, Adam V, Kizek R. Skalickova S, et al. Among authors: pekarik v. Viruses. 2015 Oct 20;7(10):5428-42. doi: 10.3390/v7102883. Viruses. 2015. PMID: 26492266 Free PMC article. Review.
BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS.
Prchalova E, Sukupova M, Malinak D, Andrys R, Sivak L, Pekarik V, Skarka A, Svobodova J, Prchal L, Fresser L, Heger Z, Musilek K. Prchalova E, et al. Among authors: pekarik v. Biomed Pharmacother. 2023 Nov;167:115490. doi: 10.1016/j.biopha.2023.115490. Epub 2023 Sep 16. Biomed Pharmacother. 2023. PMID: 37722189 Free article.
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Stark T, Ruda-Kucerova J, Iannotti FA, D'Addario C, Di Marco R, Pekarik V, Drazanova E, Piscitelli F, Bari M, Babinska Z, Giurdanella G, Di Bartolomeo M, Salomone S, Sulcova A, Maccarrone M, Wotjak CT, Starcuk Z Jr, Drago F, Mechoulam R, Di Marzo V, Micale V. Stark T, et al. Among authors: pekarik v. Neuropharmacology. 2019 Mar 1;146:212-221. doi: 10.1016/j.neuropharm.2018.11.035. Epub 2018 Nov 26. Neuropharmacology. 2019. PMID: 30496751
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Di Bartolomeo M, Stark T, Maurel OM, Iannotti FA, Kuchar M, Ruda-Kucerova J, Piscitelli F, Laudani S, Pekarik V, Salomone S, Arosio B, Mechoulam R, Maccarrone M, Drago F, Wotjak CT, Di Marzo V, Vismara M, Dell'Osso B, D'Addario C, Micale V. Di Bartolomeo M, et al. Among authors: pekarik v. Pharmacol Res. 2021 Feb;164:105357. doi: 10.1016/j.phrs.2020.105357. Epub 2020 Dec 4. Pharmacol Res. 2021. PMID: 33285233 Free article.
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
Stark T, Di Bartolomeo M, Di Marco R, Drazanova E, Platania CBM, Iannotti FA, Ruda-Kucerova J, D'Addario C, Kratka L, Pekarik V, Piscitelli F, Babinska Z, Fedotova J, Giurdanella G, Salomone S, Sulcova A, Bucolo C, Wotjak CT, Starcuk Z Jr, Drago F, Mechoulam R, Di Marzo V, Micale V. Stark T, et al. Among authors: pekarik v. Biochem Pharmacol. 2020 Jul;177:114004. doi: 10.1016/j.bcp.2020.114004. Epub 2020 Apr 28. Biochem Pharmacol. 2020. PMID: 32360362
22 results